0001654954-22-001631.txt : 20220214 0001654954-22-001631.hdr.sgml : 20220214 20220214160922 ACCESSION NUMBER: 0001654954-22-001631 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220214 DATE AS OF CHANGE: 20220214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Choy Gavin CENTRAL INDEX KEY: 0001905561 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40023 FILM NUMBER: 22631762 MAIL ADDRESS: STREET 1: 8000 MARINA BLVD, STE. 100 STREET 2: C/O GT BIOPHARMA, INC. CITY: BRISBANE STATE: CA ZIP: 94005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GT Biopharma, Inc. CENTRAL INDEX KEY: 0000109657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 941620407 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8000 MARINA BLVD STREET 2: SUITE 100 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: (800) 304-9888 MAIL ADDRESS: STREET 1: 8000 MARINA BLVD STREET 2: SUITE 100 CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: OXIS INTERNATIONAL INC DATE OF NAME CHANGE: 19940916 FORMER COMPANY: FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/ DATE OF NAME CHANGE: 19850312 4 1 section16.xml PRIMARY DOCUMENT X0306 4 2021-12-31 0000109657 GT Biopharma, Inc. GTBP 0001905561 Choy Gavin C/O GT BIOPHARMA, INC. 8000 MARINA BLVD., STE. 100 BRISBANE CA 94005 true Acting Chief Financial Officer Option to purchase Common Stock 3.05 2021-12-31 4 A false 227500 0 A 2031-12-31 Common Stock 227500 227500 D 33% on the date of grant, 33% on 6/1/22 and 34% on 6/1/23, subject to continued service and subject to full acceleration immediately prior to the consummation of a change of control. /s/ Gavin Choy 2022-02-14